Dare Bioscience, Inc.
USD2.12
+0.02 (+0.95%)
CEO
Sabrina Martucci Johnson
IPO Date
2014-04-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.08
Prev. Close
$2.10
Day Low
$2.06
Day High
$2.14
52W Low
$1.27
52W High
$9.19
Market Cap
$0.02B
Volume
0.12M
| -6.5 |
| 31 Dec 2023 | FY | -670.6% | -1074.2% | 597.5% | -141.7% | -0.28 | 0.86 | -1.0 |
| 31 Dec 2022 | FY | -201.4% | -309.5% | -278.5% | -70.6% | 0.04 | 1.36 | -2.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -99.8% | -69.3% | 0.01 | 3.44 | -3.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 2379.1% | -362.9% | -0.66 | 0.91 | -1.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -3235.7% | -191.6% | 1.82 | 1.15 | -0.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -248.8% | -213.9% | 0.00 | 6.64 | -0.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -86.5% | -80.7% | 0.00 | 8.64 | -0.6 |
| 31 Dec 2016 | FY | 47.8% | -5131.2% | -299.8% | -104.3% | 0.98 | 2.17 | -6.0 |
| -4.9 |
| 30 Sept 2025 | Q3 | 100.0% | -157505.1% | -124.7% | -11.6% | 1.03 | 1.18 | -1.9 |
| 30 Jun 2025 | Q2 | 100.0% | 18970.7% | 31.5% | -30.9% | -0.24 | 0.34 | -1.3 |
| 31 Mar 2025 | Q1 | -8935.2% | -17219.1% | 45.8% | -23.5% | -0.87 | 0.56 | -1.4 |
| 31 Dec 2024 | Q4 | 22446.0% | 8651.5% | 91.6% | -24.9% | -0.22 | 0.85 | -1.2 |
| 30 Sept 2024 | Q3 | 40.0% | -11279.4% | 316.8% | -26.0% | -3.97 | 1.14 | -1.5 |
| 30 Jun 2024 | Q2 | 100.0% | 57539.2% | 483.3% | 54.7% | 0.57 | 1.43 | 0.6 |
| 31 Mar 2024 | Q1 | -36034.1% | -72622.6% | 61.4% | -51.9% | -0.15 | 0.56 | -1.8 |
| 31 Dec 2023 | Q4 | -1092.7% | -279.8% | 100.2% | -23.8% | -0.28 | 0.86 | -1.4 |